|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01515 CR MEDICAL
Nominal 
2.550 +0.005 (+0.196%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 1,358,539 | 1,270,260 | 1,195,123 | 863,588 |
| Net Cash from / (used in) Investing Activities | -- | (326,200) | (544,725) | (2,622,095) | (494,021) |
| Net Cash from / (used in) Financing Activities | -- | (1,070,132) | (984,795) | (437,083) | (223,691) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (37,793) | (259,260) | (1,864,055) | 145,876 |
| Cash & Cash Equivalents at beginning of period | -- | 977,333 | 1,236,097 | 3,100,011 | 2,951,401 |
| Effect of Foreign Exchange Rate Changes | -- | 80 | 496 | 141 | 2,734 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 939,620 | 977,333 | 1,236,097 | 3,100,011 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 264,902 |
| %Change | -21.978% |
| EPS / (LPS) | RMB 0.210 |
| NBV Per Share (¥) | RMB 5.176 |